Individualized treatment planning
A treatment plan is built from the confirmed diagnosis, tumour type and subtype, stage, pathology and biomarker findings, previous treatment, organ function and the patient's overall health and priorities.
Medical oncology
How planning works
A treatment plan is built from the confirmed diagnosis, tumour type and subtype, stage, pathology and biomarker findings, previous treatment, organ function and the patient's overall health and priorities.
Medical oncology works with pathology, radiology, surgical and radiation oncology and — where molecular findings are relevant — Molecular Tumor Board review.
Response assessment, laboratory monitoring, side-effect review and dose or schedule review are part of ongoing care, not separate add-ons.
Prescribed systemic treatment is administered and monitored in the oncology day care centre. Selected supportive care may be provided at home after clinical assessment.
Systemic treatment types
Cytotoxic systemic treatment, used in curative, adjuvant, neoadjuvant or palliative contexts depending on the clinical situation.
Treatment directed at a specific molecular alteration, where such an alteration has been identified and a suitable agent exists.
Treatment that acts on immune regulation, considered in cancers and biomarker settings where its role is established.
Hormone-directed treatment in hormone-sensitive cancers, such as some breast and prostate cancers.
Antibody-directed delivery of a cytotoxic payload, used in specific biomarker-defined settings.
Treatment aimed at symptoms, comfort and tolerance of therapy, provided alongside cancer treatment.
Related
Treatment decisions are made after reviewing your diagnosis, reports and clinical assessment.